Trichomonas Vaginalis

CPT Code(s):
87661

Turnaround Time:
8 hours

Specimen Requirements

Preferred Specimen:
Urine or Vaginal, Anorectal, Oropharyngeal Swab

Minimum Volume:
1.0 mL (or 1 swab)

Transport Container:
PCR Media Uni Swab Sample Kit

Transport Temperature:
Room Temperature

Collection Instructions:
First void urine specimens kept at 2�30 �C must be transferred from the collection cup to the PCR Tube within 4 hours of collection, or within 24 hours when stored at 2�8 �C.

Rejection Criteria:
Specimen received in preservative other than PCR Media Uni Swab kit

Stability Criteria

Room Temperature:
12 months

Refrigerated:
12 months

Frozen:
Unacceptable

Clinical Significance

Trichomonas vaginalis has specific clinical significance and diagnostic use in detecting the presence of the Trichomonas vaginalis parasite in patients. Here are some key points regarding its clinical significance:

1. Diagnosis of Trichomoniasis: Trichomonas vaginalis is a sexually transmitted parasite that causes an infection called trichomoniasis. Trichomonas vaginalis is used to diagnose this infection in patients, particularly those who present with symptoms such as vaginal discharge, itching, burning, or discomfort during urination.

2. Screening for Asymptomatic Infections: Trichomoniasis can also be asymptomatic in some individuals, which means they may be carriers of the parasite without experiencing any noticeable symptoms. Trichomonas vaginalis is valuable for screening individuals at high risk of infection, such as sexually active individuals or those with multiple sexual partners, to identify and treat asymptomatic infections.

3. Partner Notification and Treatment: When a patient tests positive for Trichomonas vaginalis, it is important to notify and treat their sexual partners as well. The test results guide healthcare providers in providing appropriate counseling and recommending treatment for partners to prevent reinfection and further transmission.

4. Follow-up and Monitoring: Trichomonas vaginalis can also be used for follow-up and monitoring of treatment effectiveness. After completing a course of treatment, the test helps assess whether the infection has been successfully cleared. Follow-up testing may be recommended to ensure complete eradication of the parasite and to confirm treatment success.

5. Prevention of Complications: Timely detection and treatment of trichomoniasis can prevent complications associated with the infection. Trichomonas vaginalis has been linked to an increased risk of adverse pregnancy outcomes, such as preterm birth and low birth weight. Early diagnosis and treatment can help mitigate these risks and promote better maternal and fetal health.

In summary, Trichomonas vaginalis is clinically significant in the diagnosis of trichomoniasis, screening for asymptomatic infections, partner notification and treatment, follow-up and monitoring of treatment efficacy, and prevention of complications. It plays a crucial role in identifying and managing trichomoniasis infections, improving patient outcomes, and reducing the transmission of the parasite.